866-997-4948(US-Canada Toll Free)

United States Generic Drugs Market Report 2018

Published By :

QYResearch

Published Date : Jun 2018

Category :

Pharmaceutical

No. of Pages : 105 Pages

In this report, the United States Generic Drugs market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Generic Drugs in these regions, from 2013 to 2025 (forecast).

United States Generic Drugs market competition by top manufacturers/players, with Generic Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Teva
Novartis - Sandoz
Mylan
Sun Pharmaceutical
Aspen
Fresenius Kabi
Pfizer (Hospira)
Sanofi
Aurobindo
Lupin
Dr. Reddy's
Apotex
Cipla
ENDO (Par Pharmaceutical)
Stada Arzneimittel
Krka Group
Nichi-Iko Pharmaceutical
Valeant
Zydus Cadila
Hikma

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Simple Generic Drugs
Super Generic Drugs
Biosimilars
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others

Table of Contents

United States Generic Drugs Market Report 2018
1 Generic Drugs Overview
1.1 Product Overview and Scope of Generic Drugs
1.2 Classification of Generic Drugs by Product Category
1.2.1 United States Generic Drugs Market Size (Sales Volume) Comparison by Type (2013-2025)
1.2.2 United States Generic Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
1.2.3 Simple Generic Drugs
1.2.4 Super Generic Drugs
1.2.5 Biosimilars
1.3 United States Generic Drugs Market by Application/End Users
1.3.1 United States Generic Drugs Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
1.3.2 CNS
1.3.3 Cardiovascular
1.3.4 Genitourinary/Hormonal Drugs
1.3.5 Respiratory
1.3.6 Rheumatology
1.3.7 Diabetes
1.3.8 Oncology
1.3.9 Others
1.4 United States Generic Drugs Market by Region
1.4.1 United States Generic Drugs Market Size (Value) Comparison by Region (2013-2025)
1.4.2 The West Generic Drugs Status and Prospect (2013-2025)
1.4.3 Southwest Generic Drugs Status and Prospect (2013-2025)
1.4.4 The Middle Atlantic Generic Drugs Status and Prospect (2013-2025)
1.4.5 New England Generic Drugs Status and Prospect (2013-2025)
1.4.6 The South Generic Drugs Status and Prospect (2013-2025)
1.4.7 The Midwest Generic Drugs Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Generic Drugs (2013-2025)
1.5.1 United States Generic Drugs Sales and Growth Rate (2013-2025)
1.5.2 United States Generic Drugs Revenue and Growth Rate (2013-2025)

2 United States Generic Drugs Market Competition by Players/Suppliers
2.1 United States Generic Drugs Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Generic Drugs Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Generic Drugs Average Price by Players/Suppliers (2013-2018)
2.4 United States Generic Drugs Market Competitive Situation and Trends
2.4.1 United States Generic Drugs Market Concentration Rate
2.4.2 United States Generic Drugs Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Generic Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 United States Generic Drugs Sales (Volume) and Revenue (Value) by Region (2013-2018)
3.1 United States Generic Drugs Sales and Market Share by Region (2013-2018)
3.2 United States Generic Drugs Revenue and Market Share by Region (2013-2018)
3.3 United States Generic Drugs Price by Region (2013-2018)

4 United States Generic Drugs Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)
4.1 United States Generic Drugs Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Generic Drugs Revenue and Market Share by Type (2013-2018)
4.3 United States Generic Drugs Price by Type (2013-2018)
4.4 United States Generic Drugs Sales Growth Rate by Type (2013-2018)

5 United States Generic Drugs Sales (Volume) by Application (2013-2018)
5.1 United States Generic Drugs Sales and Market Share by Application (2013-2018)
5.2 United States Generic Drugs Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 United States Generic Drugs Players/Suppliers Profiles and Sales Data
6.1 Teva
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Generic Drugs Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Teva Generic Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 Novartis - Sandoz
6.2.2 Generic Drugs Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Novartis - Sandoz Generic Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 Mylan
6.3.2 Generic Drugs Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Mylan Generic Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 Sun Pharmaceutical
6.4.2 Generic Drugs Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Sun Pharmaceutical Generic Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 Aspen
6.5.2 Generic Drugs Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Aspen Generic Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 Fresenius Kabi
6.6.2 Generic Drugs Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Fresenius Kabi Generic Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
6.7 Pfizer (Hospira)
6.7.2 Generic Drugs Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Pfizer (Hospira) Generic Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Main Business/Business Overview
6.8 Sanofi
6.8.2 Generic Drugs Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Sanofi Generic Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.8.4 Main Business/Business Overview
6.9 Aurobindo
6.9.2 Generic Drugs Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Aurobindo Generic Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.9.4 Main Business/Business Overview
6.10 Lupin
6.10.2 Generic Drugs Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Lupin Generic Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.10.4 Main Business/Business Overview
6.11 Dr. Reddy's
6.12 Apotex
6.13 Cipla
6.14 ENDO (Par Pharmaceutical)
6.15 Stada Arzneimittel
6.16 Krka Group
6.17 Nichi-Iko Pharmaceutical
6.18 Valeant
6.19 Zydus Cadila
6.20 Hikma

7 Generic Drugs Manufacturing Cost Analysis
7.1 Generic Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Generic Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Generic Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Generic Drugs Major Manufacturers in 2017
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Generic Drugs Market Size (Value and Volume) Forecast (2018-2025)
11.1 United States Generic Drugs Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Generic Drugs Sales Volume Forecast by Type (2018-2025)
11.3 United States Generic Drugs Sales Volume Forecast by Application (2018-2025)
11.4 United States Generic Drugs Sales Volume Forecast by Region (2018-2025)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer

List of Table

List of Tables and Figures

Figure Product Picture of Generic Drugs
Figure United States Generic Drugs Market Size (K MT) by Type (2013-2025)
Figure United States Generic Drugs Sales Volume Market Share by Type (Product Category) in 2017
Figure Simple Generic Drugs Product Picture
Figure Super Generic Drugs Product Picture
Figure Biosimilars Product Picture
Figure United States Generic Drugs Market Size (K MT) by Application (2013-2025)
Figure United States Sales Market Share of Generic Drugs by Application in 2017
Figure CNS Examples
Table Key Downstream Customer in CNS
Figure Cardiovascular Examples
Table Key Downstream Customer in Cardiovascular
Figure Genitourinary/Hormonal Drugs Examples
Table Key Downstream Customer in Genitourinary/Hormonal Drugs
Figure Respiratory Examples
Table Key Downstream Customer in Respiratory
Figure Rheumatology Examples
Table Key Downstream Customer in Rheumatology
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Generic Drugs Market Size (Million USD) by Region (2013-2025)
Figure The West Generic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Generic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Generic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Generic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Generic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Generic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Generic Drugs Sales (K MT) and Growth Rate (2013-2025)
Figure United States Generic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Generic Drugs Market Major Players Product Sales Volume (K MT) (2013-2018)
Table United States Generic Drugs Sales (K MT) of Key Players/Suppliers (2013-2018)
Table United States Generic Drugs Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Generic Drugs Sales Share by Players/Suppliers
Figure 2017 United States Generic Drugs Sales Share by Players/Suppliers
Figure United States Generic Drugs Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Generic Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Generic Drugs Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Generic Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Generic Drugs Revenue Share by Players/Suppliers
Table United States Market Generic Drugs Average Price (USD/MT) of Key Players/Suppliers (2013-2018)
Figure United States Market Generic Drugs Average Price (USD/MT) of Key Players/Suppliers in 2017
Figure United States Generic Drugs Market Share of Top 3 Players/Suppliers
Figure United States Generic Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Generic Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Generic Drugs Product Category
Table United States Generic Drugs Sales (K MT) by Region (2013-2018)
Table United States Generic Drugs Sales Share by Region (2013-2018)
Figure United States Generic Drugs Sales Share by Region (2013-2018)
Figure United States Generic Drugs Sales Market Share by Region in 2017
Table United States Generic Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Generic Drugs Revenue Share by Region (2013-2018)
Figure United States Generic Drugs Revenue Market Share by Region (2013-2018)
Figure United States Generic Drugs Revenue Market Share by Region in 2017
Table United States Generic Drugs Price (USD/MT) by Region (2013-2018)
Table United States Generic Drugs Sales (K MT) by Type (2013-2018)
Table United States Generic Drugs Sales Share by Type (2013-2018)
Figure United States Generic Drugs Sales Share by Type (2013-2018)
Figure United States Generic Drugs Sales Market Share by Type in 2017
Table United States Generic Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Generic Drugs Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Generic Drugs by Type (2013-2018)
Figure Revenue Market Share of Generic Drugs by Type in 2017
Table United States Generic Drugs Price (USD/MT) by Types (2013-2018)
Figure United States Generic Drugs Sales Growth Rate by Type (2013-2018)
Table United States Generic Drugs Sales (K MT) by Application (2013-2018)
Table United States Generic Drugs Sales Market Share by Application (2013-2018)
Figure United States Generic Drugs Sales Market Share by Application (2013-2018)
Figure United States Generic Drugs Sales Market Share by Application in 2017
Table United States Generic Drugs Sales Growth Rate by Application (2013-2018)
Figure United States Generic Drugs Sales Growth Rate by Application (2013-2018)
Table Teva Basic Information List
Table Teva Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Teva Generic Drugs Sales Growth Rate (2013-2018)
Figure Teva Generic Drugs Sales Market Share in United States (2013-2018)
Figure Teva Generic Drugs Revenue Market Share in United States (2013-2018)
Table Novartis - Sandoz Basic Information List
Table Novartis - Sandoz Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Novartis - Sandoz Generic Drugs Sales Growth Rate (2013-2018)
Figure Novartis - Sandoz Generic Drugs Sales Market Share in United States (2013-2018)
Figure Novartis - Sandoz Generic Drugs Revenue Market Share in United States (2013-2018)
Table Mylan Basic Information List
Table Mylan Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Mylan Generic Drugs Sales Growth Rate (2013-2018)
Figure Mylan Generic Drugs Sales Market Share in United States (2013-2018)
Figure Mylan Generic Drugs Revenue Market Share in United States (2013-2018)
Table Sun Pharmaceutical Basic Information List
Table Sun Pharmaceutical Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Sun Pharmaceutical Generic Drugs Sales Growth Rate (2013-2018)
Figure Sun Pharmaceutical Generic Drugs Sales Market Share in United States (2013-2018)
Figure Sun Pharmaceutical Generic Drugs Revenue Market Share in United States (2013-2018)
Table Aspen Basic Information List
Table Aspen Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Aspen Generic Drugs Sales Growth Rate (2013-2018)
Figure Aspen Generic Drugs Sales Market Share in United States (2013-2018)
Figure Aspen Generic Drugs Revenue Market Share in United States (2013-2018)
Table Fresenius Kabi Basic Information List
Table Fresenius Kabi Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Fresenius Kabi Generic Drugs Sales Growth Rate (2013-2018)
Figure Fresenius Kabi Generic Drugs Sales Market Share in United States (2013-2018)
Figure Fresenius Kabi Generic Drugs Revenue Market Share in United States (2013-2018)
Table Pfizer (Hospira) Basic Information List
Table Pfizer (Hospira) Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Pfizer (Hospira) Generic Drugs Sales Growth Rate (2013-2018)
Figure Pfizer (Hospira) Generic Drugs Sales Market Share in United States (2013-2018)
Figure Pfizer (Hospira) Generic Drugs Revenue Market Share in United States (2013-2018)
Table Sanofi Basic Information List
Table Sanofi Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Sanofi Generic Drugs Sales Growth Rate (2013-2018)
Figure Sanofi Generic Drugs Sales Market Share in United States (2013-2018)
Figure Sanofi Generic Drugs Revenue Market Share in United States (2013-2018)
Table Aurobindo Basic Information List
Table Aurobindo Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Aurobindo Generic Drugs Sales Growth Rate (2013-2018)
Figure Aurobindo Generic Drugs Sales Market Share in United States (2013-2018)
Figure Aurobindo Generic Drugs Revenue Market Share in United States (2013-2018)
Table Lupin Basic Information List
Table Lupin Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Lupin Generic Drugs Sales Growth Rate (2013-2018)
Figure Lupin Generic Drugs Sales Market Share in United States (2013-2018)
Figure Lupin Generic Drugs Revenue Market Share in United States (2013-2018)
Table Dr. Reddy's Basic Information List
Table Apotex Basic Information List
Table Cipla Basic Information List
Table ENDO (Par Pharmaceutical) Basic Information List
Table Stada Arzneimittel Basic Information List
Table Krka Group Basic Information List
Table Nichi-Iko Pharmaceutical Basic Information List
Table Valeant Basic Information List
Table Zydus Cadila Basic Information List
Table Hikma Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Generic Drugs
Figure Manufacturing Process Analysis of Generic Drugs
Figure Generic Drugs Industrial Chain Analysis
Table Raw Materials Sources of Generic Drugs Major Players/Suppliers in 2017
Table Major Buyers of Generic Drugs
Table Distributors/Traders List
Figure United States Generic Drugs Sales Volume (K MT) and Growth Rate Forecast (2018-2025)
Figure United States Generic Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Generic Drugs Price (USD/MT) Trend Forecast (2018-2025)
Table United States Generic Drugs Sales Volume (K MT) Forecast by Type (2018-2025)
Figure United States Generic Drugs Sales Volume (K MT) Forecast by Type (2018-2025)
Figure United States Generic Drugs Sales Volume (K MT) Forecast by Type in 2025
Table United States Generic Drugs Sales Volume (K MT) Forecast by Application (2018-2025)
Figure United States Generic Drugs Sales Volume (K MT) Forecast by Application (2018-2025)
Figure United States Generic Drugs Sales Volume (K MT) Forecast by Application in 2025
Table United States Generic Drugs Sales Volume (K MT) Forecast by Region (2018-2025)
Table United States Generic Drugs Sales Volume Share Forecast by Region (2018-2025)
Figure United States Generic Drugs Sales Volume Share Forecast by Region (2018-2025)
Figure United States Generic Drugs Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *